Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
Research Site, Birmingham, Alabama Research Site, Loma Linda, California Research Site, Jacksonville, Florida Research Site, Orlando, Florida Research Site, Lenexa, Kansas